Invention Grant
US09243059B2 Humanized anti-N2 antibodies and methods of treating ischemia-reperfusion injury
有权
人源化抗N2抗体和治疗缺血再灌注损伤的方法
- Patent Title: Humanized anti-N2 antibodies and methods of treating ischemia-reperfusion injury
- Patent Title (中): 人源化抗N2抗体和治疗缺血再灌注损伤的方法
-
Application No.: US14206316Application Date: 2014-03-12
-
Publication No.: US09243059B2Publication Date: 2016-01-26
- Inventor: Robyn J. Puro
- Applicant: DecImmune Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: DecImmune Therapeutics, Inc.
- Current Assignee: DecImmune Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Elmore Patent Law Group, P.C.
- Agent Mahreen Chaudhry Hoda; Carolyn S. Elmore
- Main IPC: C07K16/18
- IPC: C07K16/18 ; A61K39/395 ; A61K39/00
Abstract:
The present invention encompasses humanized antibodies that specifically bind N2 peptide, methods for the preparation thereof and methods for the use thereof.
Public/Granted literature
- US20140271627A1 HUMANIZED, ANTI-N2 ANTIBODIES Public/Granted day:2014-09-18
Information query
